/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | CHECHEMED CORP |
|---|---|
| Last close | $528.05close 2026-11-06 |
| Change % | -1.07%close 2026-11-06 |
| Market cap | $6.9Bclose 2026-11-06 |
| P/E | 28.8FY to 2025-12-31 |
| Revenue | $2.5B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2025-12-31 Filing10-K · 0001562762-26-000020 · filed 2026-02-27 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 4.1%FY to 2025-12-31 |
| Net income | $265238⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEFR14A · 0001562762-26-000052 · filed 2026-04-09 Open the filing on EDGAR →Open the XBRL payload →CiteCHEMED CORP (CHE), us-gaap:NetIncomeLoss: 265,238 USD, fiscal year ended 2025-12-31. Form DEFR14A, accession 0001562762-26-000052, filed 2026-04-09. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000019584/us-gaap/NetIncomeLoss.json |
| Net margin | 0.0%FY to 2025-12-31 |
| EPS (diluted) | $18.34⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001562762-26-000020 · filed 2026-02-27 Open the filing on EDGAR →Open the XBRL payload →CiteCHEMED CORP (CHE), us-gaap:EarningsPerShareDiluted: 18.34 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001562762-26-000020, filed 2026-02-27. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000019584/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 4FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | 12.45FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | 02-19 → 03-01 |